Thrombolytic therapy in the management of acute myocardial infarction (AMI) serves to dissolve clots obstructing coronary arteries, thereby restoring blood flow to the heart muscle. This therapy is indicated when there's evidence of ST-segment elevation on an EKG, suggestive of a complete blockage in a coronary artery. Additionally, patient history, signs, and symptoms such as chest pain corroborating with the timing of symptom onset should be considered before administration. Thrombolytics are typically administered when percutaneous coronary intervention is not available within a timely manner. The use of adjunctive therapies may be necessary based on the patient's response and specific medical history .

The systematic approach for managing refractory ventricular fibrillation (VF) or pulseless ventricular tachycardia (VT) includes a series of steps starting with the ABCs (Airway, Breathing, Circulation) and the mnemonic OMI (Oxygenation, Monitor, IV). The next step involves ICEM (IV access, CPR, ET intubation, Monitors) to support breathing and circulation. Electrical intervention, specifically defibrillation, is critical to restore normal heart rhythm; start with a defibrillation shock and proceed as necessary with 360 joules for monophasic waveform and varying joule settings for biphasic waveforms. Pharmacologic interventions like administering epinephrine or vasopressin can increase coronary and cerebral perfusion pressures, thereby improving the likelihood of successfully restoring a normal rhythm. CPR must be provided for 2 minutes with rhythm checks interspersed. Consideration of potential underlying causes, such as Acute Myocardial Infarction (AMI) or hypoxia, is crucial to address the root issue .

When managing asystole, the protocol requires confirming the rhythm in two leads to rule out any errors like loose leads or signal interference. Pharmacologic interventions include administering epinephrine 1 mg IV push every 3-5 minutes or a single dose of vasopressin 40 units IV, accompanied by CPR for 2 minutes between administrations. Potential causes such as Acute Myocardial Infarction (AMI), hypoxia, hypoglycemia, and acidosis should be ruled out and addressed as possible reversible factors. Termination of resuscitation efforts may be considered after 10 minutes of sustained asystole if there are no reversible causes identified and the patient's condition shows no signs of improvement despite exhaustive resuscitative attempts .

The mnemonic ICEM is used in ACLS to remind healthcare providers of the critical steps in a cardiac emergency: IV access, CPR, ET intubation, and Monitor (EKG). IV access is necessary for drug administration; CPR maintains circulation and oxygen delivery to vital organs; ET (endotracheal) intubation ensures a secure airway for effective ventilation; monitoring via EKG allows continuous observation of the heart's electrical activity to guide treatment decisions. Each component is crucial for maintaining circulatory support, ensuring effective resuscitation, and providing a pathway for corrective measures .

In stable supraventricular tachycardia (SVT), the management protocol includes the ABC approach, OMI (Oxygenation, Monitoring, IV access), vagal maneuvers, and pharmacologic intervention starting with adenosine (6 mg followed by 12 mg as necessary, up to a maximum of 18 mg). Other medications like beta-blockers, Verapamil, or Cardizem might be used if the vagal maneuvers are ineffective. In contrast, management for unstable SVT begins with the ABC and OMI approach as well. If medications are ineffective or the patient's condition deteriorates, sedation followed by cardioversion is recommended, starting with incremental energy levels from 50J to 360J, depending on response .

The administration of magnesium sulfate in cases of refractory ventricular fibrillation or pulseless ventricular tachycardia is recommended when hypomagnesemia is suspected. Magnesium deficiency can precipitate or exacerbate arrhythmias, and replacing magnesium can stabilize cardiac electrical activity and mitigate torsades de pointes. The typical dose for suspected hypomagnesemia is 1-2 grams in 10 mL of D5W, which acts to correct the deficits rapidly. The use of magnesium sulfate is particularly indicated in scenarios with a history of prolonged QT syndrome or digitalis toxicity, where magnesium can have significant therapeutic effects .

In the context of cardioversion, different arrhythmias require different energy settings. For unstable VT and atrial fibrillation, start cardioversion at 100 joules, and if necessary, increase incrementally to 200, 300, and 360 joules as needed. Flutter and SVT often require less energy, starting as low as 50 joules due to the nature of these arrhythmias and their typical reentrant electrical pathways, which are usually terminated with less energy compared to AFib or VT. The precise energy setting is adjusted based on patient response and specific arrhythmic characteristics, ensuring effective but safe restoration of sinus rhythm .

For managing bradycardia, pharmacologic interventions include administering atropine at 0.5 mg every 5 minutes up to a total of 3.0 mg. Atropine helps by increasing heart rate through antagonism of the vagus nerve's parasympathetic effects on the heart. If atropine is ineffective, transcutaneous pacing is recommended. Dopamine drips at 2-20 micrograms/kg/min or epinephrine drips in the same dosage range can also be initiated. These agents act as vasopressors, constricting blood vessels and increasing heart rate and cardiac output, which are critical in maintaining adequate perfusion when the heart is bradycardic .

When using transcutaneous pacing for hemodynamically unstable bradycardia or heart blocks, several considerations are essential. Firstly, ensure adequate sedation and analgesia as the procedure can be uncomfortable. Use in cases where pharmacologic therapies like atropine or drip medications are ineffective. Monitor the patient's response to pacing, and verify capture, which is confirmed when a pacing spike is followed by a broad complex on the EKG and corresponding pulse. Consider the underlying cause of instability and address reversible causes concurrently. In cases of persistent instability despite transcutaneous pacing, evaluate the need for transvenous pacing to provide a more reliable rate control .

Early defibrillation is critical for successful outcomes in refractory ventricular fibrillation as it restores normal heart rhythm, which is essential for preventing cardiac arrest and subsequent organ damage. The effectiveness of defibrillation diminishes as time without intervention increases; the chances of survival decrease significantly with every passing minute without electrical intervention. This is because prolonged VF leads to deterioration of myocardial cells and electrical pathways, decreasing the likelihood that a shock will successfully depolarize the heart to reset its rhythm. Timely defibrillation paired with ongoing CPR maximizes the chance of neuro intact survival .